IBO Earnings — Impact BioMedical, Inc. Post-ER Performance | BigEarnings
IBO — Impact BioMedical, Inc.
XASE
Price$0.46
Market Cap$49.2M
P/E—
52W Range$0.37 – $0.83
Next Earnings2026-08-13
About Impact BioMedical, Inc.
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
